Clever Culture Systems 

$0
1
+$0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16FebExpected
Q4 0
Q4 2020
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.01
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.000467075

Financials

30.7%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
7.07MRevenue
2.17MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LBTTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products which align with LBT's focus on medical diagnostics and technology.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. provides a range of products for the healthcare industry including clinical diagnostics and life science research, competing in the diagnostics space.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services, overlapping with LBT's medical technology sector.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific Inc. offers analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents, competing in the healthcare and diagnostics field.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights, directly competing in the diagnostics and research market.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions that compete with LBT's technology offerings in the healthcare sector.
Bio-Techne
TECH
Mkt Cap9.74B
Bio-Techne Corporation develops, manufactures, and sells biotechnology reagents and instruments for the research and clinical diagnostic markets, overlapping with LBT's market.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health, Inc. focuses on helping conquer cancer globally through use of its proprietary blood tests, vast data sets, and advanced analytics, similar to LBT's focus on innovative diagnostic solutions.

About

LBT Innovations Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.
Show more...
CEO
Mr. Brenton John Barnes
Country
AU
ISIN
AU0000367153

Listings

0 Comments

Share your thoughts

FAQ

What is Clever Culture Systems stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Clever Culture Systems stocks are traded under the ticker LBTTF.
When is the next Clever Culture Systems earnings date?
Clever Culture Systems is going to release the next earnings report on September 02, 2026.
What were Clever Culture Systems earnings last quarter?
LBTTF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Clever Culture Systems revenue for the last year?
Clever Culture Systems revenue for the last year amounts to 7.07M USD.
What is Clever Culture Systems net income for the last year?
LBTTF net income for the last year is 2.17M USD.
In which sector is Clever Culture Systems located?
Clever Culture Systems operates in the Healthcare sector.
When did Clever Culture Systems complete a stock split?
Clever Culture Systems has not had any recent stock splits.
Where is Clever Culture Systems headquartered?
Clever Culture Systems is headquartered in Adelaide, AU.